The pharmacological activation of LXRα with the synthetic agonist T0901317 markedly attenuated pulmonary inflammation, reduced alveolar protein leakage, and improved the histopathological scores in both murine and cellular models of ALI. Here, NR1H3 is linked to acute respiratory distress syndrome.